Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases
Authors
Keywords
-
Journal
MOLECULES
Volume 19, Issue 11, Pages 18781-18816
Publisher
MDPI AG
Online
2014-11-17
DOI
10.3390/molecules191118781
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial
- (2015) Dana Turcotte et al. PAIN MEDICINE
- Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD1G93ATransgenic Mice and Evaluation of a Sativex®-like Combination of Phytocannabinoids: Interest for Future Therapies in Amyotrophic Lateral Sclerosis
- (2014) Miguel Moreno-Martet et al. CNS Neuroscience & Therapeutics
- Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review
- (2014) Latha Velayudhan et al. CURRENT PHARMACEUTICAL DESIGN
- Changes in GABA and glutamate concentrations during memory tasks in patients with Parkinson’s disease undergoing DBS surgery
- (2014) Robert J. Buchanan et al. Frontiers in Human Neuroscience
- Use of Natural Compounds in the Management of Diabetic Peripheral Neuropathy
- (2014) Maria Galuppo et al. MOLECULES
- Neuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice
- (2014) Sara Valdeolivas et al. Neurotherapeutics
- Huntington’s disease: pathogenesis to animal models
- (2014) Puneet Kumar et al. Pharmacological Reports
- A restricted population of CB1 cannabinoid receptors with neuroprotective activity
- (2014) A. Chiarlone et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease
- (2014) Laetitia Francelle et al. Frontiers in Cellular Neuroscience
- The influence of cannabinoids on generic traits of neurodegeneration
- (2013) S G Fagan et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial
- (2013) John Zajicek et al. LANCET NEUROLOGY
- Mechanisms of cannabidiol neuroprotection in hypoxic–ischemic newborn pigs: Role of 5HT1A and CB2 receptors
- (2013) M. Ruth Pazos et al. NEUROPHARMACOLOGY
- Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis
- (2013) R. Ribeiro et al. NEUROSCIENCE
- Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+Cells Through PPARγ Involvement
- (2013) Caterina Scuderi et al. PHYTOTHERAPY RESEARCH
- Sativex-like Combination of Phytocannabinoids is Neuroprotective in Malonate-Lesioned Rats, an Inflammatory Model of Huntington’s Disease: Role of CB1 and CB2 Receptors
- (2012) Sara Valdeolivas et al. ACS Chemical Neuroscience
- Cannabidivarin is anticonvulsant in mouse and rat
- (2012) AJ Hill et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoids and Parkinsons Disease
- (2012) Moises Garcia-Arencibia et al. CNS & Neurological Disorders-Drug Targets
- Glutamate Receptors as Therapeutic Targets for Parkinsons Disease
- (2012) Kari Johnson et al. CNS & Neurological Disorders-Drug Targets
- A Synopsis on the Role of Tyrosine Hydroxylase in Parkinson’s Disease
- (2012) Shams Tabrez et al. CNS & Neurological Disorders-Drug Targets
- Structure and Function of ∆1-Tetrahydrocannabinolic Acid (THCA) Synthase, the Enzyme Controlling the Psychoactivity of Cannabis sativa
- (2012) Yoshinari Shoyama et al. JOURNAL OF MOLECULAR BIOLOGY
- Cannabidiol administration after hypoxia–ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function
- (2012) M.R. Pazos et al. NEUROPHARMACOLOGY
- Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
- (2012) A. C. Campos et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR
- (2012) Nizar Happyana et al. PHYTOCHEMISTRY
- Neurological diseases and pain
- (2011) David Borsook BRAIN
- Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson's disease
- (2011) C García et al. BRITISH JOURNAL OF PHARMACOLOGY
- Prospects for cannabinoid therapies in basal ganglia disorders
- (2011) Javier Fernández-Ruiz et al. BRITISH JOURNAL OF PHARMACOLOGY
- Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease
- (2011) Onintza Sagredo et al. JOURNAL OF NEUROSCIENCE RESEARCH
- The projected effect of risk factor reduction on Alzheimer's disease prevalence
- (2011) Deborah E Barnes et al. LANCET NEUROLOGY
- Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease
- (2011) A. M. Martin-Moreno et al. MOLECULAR PHARMACOLOGY
- Investigational Therapies for Ischemic Stroke: Neuroprotection and Neurorecovery
- (2011) Preeti Sahota et al. Neurotherapeutics
- N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor
- (2010) Douglas McHugh et al. BMC NEUROSCIENCE
- Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington's disease
- (2010) EL Scotter et al. BRITISH JOURNAL OF PHARMACOLOGY
- GPR55 ligands promote receptor coupling to multiple signalling pathways
- (2010) Christopher M Henstridge et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effects of cannabinoids and cannabinoid-enrichedCannabisextracts on TRP channels and endocannabinoid metabolic enzymes
- (2010) Luciano De Petrocellis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Receptors and Channels Targeted by Synthetic Cannabinoid Receptor Agonists and Antagonists
- (2010) R. Pertwee CURRENT MEDICINAL CHEMISTRY
- Δ9-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats
- (2010) Andrew J. Hill et al. EPILEPSIA
- Interaction between cytokines, cannabinoids and the nervous system
- (2010) Lucie Jean-Gilles et al. IMMUNOBIOLOGY
- Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells
- (2010) S. Oka et al. JOURNAL OF BIOCHEMISTRY
- Acute and chronic cannabinoid extracts administration affects motor function in a CREAE model of multiple sclerosis
- (2010) Elena Buccellato et al. JOURNAL OF ETHNOPHARMACOLOGY
- Inflammatory mechanisms in ischemic stroke: role of inflammatory cells
- (2010) Rong Jin et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Huntington's disease: from molecular pathogenesis to clinical treatment
- (2010) Christopher A Ross et al. LANCET NEUROLOGY
- Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients
- (2010) Valerio Pisani et al. MOVEMENT DISORDERS
- Homeostatic changes of the endocannabinoid system in Parkinson's disease
- (2010) Valerio Pisani et al. MOVEMENT DISORDERS
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
- (2010) R. G. Pertwee et al. PHARMACOLOGICAL REVIEWS
- Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
- (2010) Chiara Zuccato et al. PHYSIOLOGICAL REVIEWS
- Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity
- (2009) Javier Palazuelos et al. BRAIN
- The complexity of neurobiological processes in acute ischemic stroke
- (2009) R. Brouns et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Towards a Reconceptualization of Striatal Interactions Between Glutamatergic and Dopaminergic Neurotransmission and Their Contribution to the Production of Movements
- (2009) Helene David Current Neuropharmacology
- Cannabinoid CB2receptor agonists protect the striatum against malonate toxicity: Relevance for Huntington's disease
- (2009) Onintza Sagredo et al. GLIA
- Cannabidiol Targets Mitochondria to Regulate Intracellular Ca2+ Levels
- (2009) D. Ryan et al. JOURNAL OF NEUROSCIENCE
- Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo
- (2009) N. A. Jones et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Plasma endocannabinoid levels in multiple sclerosis
- (2009) L. Jean-Gilles et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- A pilot study using nabilone for symptomatic treatment in Huntington's disease
- (2009) Adrienne Curtis et al. MOVEMENT DISORDERS
- The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic–ischemic brain damage in mice is mediated by CB2 and adenosine receptors
- (2009) A. Castillo et al. NEUROBIOLOGY OF DISEASE
- Cannabinoids as pharmacotherapies for neuropathic pain: From the bench to the bedside
- (2009) Elizabeth J. Rahn et al. Neurotherapeutics
- Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
- (2009) Angelo A. Izzo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Effects of Δ9-tetrahydrocannabivarin on [35S]GTPγS binding in mouse brain cerebellum and piriform cortex membranes
- (2008) I Dennis et al. BRITISH JOURNAL OF PHARMACOLOGY
- The phytocannabinoid Δ9-tetrahydrocannabivarin modulates inhibitory neurotransmission in the cerebellum
- (2008) Y-L Ma et al. BRITISH JOURNAL OF PHARMACOLOGY
- Phytochemical and genetic analyses of ancient cannabis from Central Asia
- (2008) Ethan B. Russo et al. JOURNAL OF EXPERIMENTAL BOTANY
- Neuroprotective Effects of the Nonpsychoactive Cannabinoid Cannabidiol in Hypoxic-Ischemic Newborn Piglets
- (2008) Francisco J Alvarez et al. PEDIATRIC RESEARCH
- Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats
- (2008) Alline Cristina Campos et al. PSYCHOPHARMACOLOGY
- Should peripheral CB1 cannabinoid receptors be selectively targeted for therapeutic gain?
- (2008) George Kunos et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- The peripheral cannabinoid receptor knockout mice: an update
- (2007) N E Buckley BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid CB2receptors in human brain inflammation
- (2007) C Benito et al. BRITISH JOURNAL OF PHARMACOLOGY
- Novel cannabinoid receptors
- (2007) A J Brown BRITISH JOURNAL OF PHARMACOLOGY
- Control of Spasticity in a Multiple Sclerosis Model is mediated by CB1, not CB2, Cannabinoid Receptors
- (2007) G Pryce et al. BRITISH JOURNAL OF PHARMACOLOGY
- The orphan receptor GPR55 is a novel cannabinoid receptor
- (2007) E Ryberg et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS expression
- (2007) G Esposito et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now